JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Landiolol (also known as LDLL600 and ONO 1101) is a beta1 selective, ultra-short-acting beta1-adrenergic blocker which is useful for managing supraventricular tachyarrhythmias in sepsis. Landiolol is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an anti-arrhythmic agent. Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients.
References: World J Crit Care Med. 2015 Aug 4; 4(3):251-7.
Related CAS: 144481-98-1 (HCl); 133242-30-5 (free base)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!